Histologically, nevi can be classified as Junctional, Compound or Intramucosal, with intramucosal being the more common type in the oral cavity
Mong qu khch thng cm
discuss with doctor if severe Week 1316: Maintenance Dose (9mg or continuing to 12mg) For 9mg group (maintenance): Side effects stabilize Nausea decreases (2025% still experiencing) Dysesthesia: 8.8% incidence (mild) Body adapting well For 12mg group (final increase): GI effects may temporarily worsen (4045% nausea) Dysesthesia peaks (20.9% incidence) This is the "make or break" dose highest efficacy, highest side effects Duration: 12 weeks adjustment period Week 17+: Long-Term Maintenance Side effects: Nausea: Decreases to 1525% (down from 4045%) Diarrhea: Improves to 1020% Dysesthesia: Stable at 8.820.9% (doesn't worsen) Most people feel "normal" except for reduced appetite Key point: Side effects are WORST during dose escalation (weeks 116)
Other adverse events include nasopharyngitis, hypoglycemia, increased lipase levels, lack of appetite, gastroparesis, bowel obstruction, abdominal pain, dyspepsia, constipation, influenza symptoms, and headaches [28]
it can feel exhausting
More than 80 peptide-based drugs have been approved worldwide for a range of conditions, reflecting how important peptide signaling is in medicine
